Steve Levine, MD, Compass Pathways

Psychiatry faces a significant paradigm shift due to the promise of psychedelic therapy. Treating patients with treatment-resistant depression or PTSD often highlights the limitations of current conventional options and the sense of helplessness felt by clinicians. Psychedelic research offers a new, hopeful frontier for addressing these deeply complex mental health conditions. By focusing on the personal stories and human experiences of suffering, the drive to improve therapeutic outcomes becomes a central, relentless pursuit within the field.